What Researchers Did
Researchers evaluated the utility of FDG-PET and 3-phase bone scintigraphy for diagnosing and managing medication-related osteonecrosis of the jaw (MRONJ).
What They Found
The study found that medication-related osteonecrosis of the jaw (MRONJ) cases exhibited significantly higher standardised uptake values (SUV) on FDG-PET imaging. This suggests that FDG-PET and 3-phase bone scintigraphy are valuable tools for evaluating the extent of necrosis and infection in MRONJ.
Canadian Relevance
This study has no direct Canadian connection as it was conducted by researchers in Japan and does not involve Canadian participants or healthcare systems.
Study Limitations
The abstract does not explicitly state study limitations, but the brevity of the reported findings suggests a need for further research with larger cohorts.